Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.92 -0.14 (-1.74%)
As of: Nov 12, 2026 · 2:13 PM EST

Eupraxia Pharmaceuticals (EPRX) Sales of Property, Plant and Equipment (2024)

Updated

Eupraxia Pharmaceuticals' Sales of Property, Plant and Equipment came in at $558.00 for Q4 2024.

Analysis

Eupraxia Pharmaceuticals (EPRX) Sales of Property, Plant and Equipment (2024) Analysis & Trends

For FY2024, Eupraxia Pharmaceuticals' Sales of Property, Plant and Equipment was $29,068.

  • Going back by year, Sales of Property, Plant and Equipment was $242.00 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -4.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 558.00
API Access

Eupraxia Pharmaceuticals Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=EPRX&period=max&api_key=YOUR_API_KEY